Hospitals and health systems engaged in clinical trials enjoy several benefits — the ability to provide the latest treatment options to patients, the prestige of being a research organization, as well ...

Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Together, the panelists discussed the multifaceted challenges that rural communities face in accessing clinical trials and offered actionable strategies to overcome these barriers. Breaking Down ...

Patients today are more involved in their healthcare choices than ever before, and gaining access to accurate, relevant and easily understandable information can help empower them to make more ...

International Women’s Day, dedicated to celebrating women’s social and political achievements and raising awareness of gender inequities, is observed every March 8.In recognition of the observance, ...

Among the many catchphrases of the Affordable Care Act individual mandates, pre-existing conditions clinical trials is one that has flown under the radar. But in terms of immediate impact, it is one ...

Clinical trials stand as a cornerstone in the continuous quest for advancing medical knowledge and patient care. These research studies test new ways to prevent, detect or treat diseases and are ...

A cancer diagnosis presents patients with complex treatment decisions. While traditional therapies like surgery, chemotherapy, and radiation remain standard options, clinical trials offer additional ...

Digital databases for clinical trial searches have already changed healthcare accessibility, bringing critical information about clinical trials to the patients who need it – and to the physicians who ...

AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate them.

Daiichi Sankyo announced that the first patient has been dosed in the global phase 3 TROPION-Lung17 trial. The study is evaluating DATROWAY in patients with locally advanced or metastatic nonsquamous ...

Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...